Dr. Bevilacqua invited panelist at ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
BOSTON, MA - SEPTEMBER 5, 2019 - Dr. Michael Bevilacqua, CEO and CSO of Amicrobe, was an invited panelist at American Society of Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases’ (ESCMID) annual Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance. The joint conference brought together scientists from around the world to discuss the challenges and opportunities in new product development.
Dr. Bevilacqua delivered a brief presentation and served as a panelist in a session titled “Overview of CARB-X Model – More Than Just the Money: CARB-X Product Developers Panel”. The presentation can be found here.